Symptoms of an overactive bladder include frequent urination, urgency and sometimes incontinence. (A urine infection needs to ...

Dear Dr. Roach: My son, age 52, had recent lab results showing that his Lipoprotein (a) level was elevated, at 172 nmol/L. He ...

Cystic fibrosis treatments are improving patients’ quality of life. Three physicians from University of Iowa Health Care ...

Artificial intelligence in medicine is no longer a distant idea. It is already part of hospitals, clinics, and research labs.

A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...

Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from Australia.

A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...

Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...

To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe ...

ROCHESTER — Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart ...

Scientists looking to provide relief for people with inflammatory bowel disease have turned to an unusual source for inspiration: barnacles. Inflammatory bowel disease (IBD), such as Crohn’s disease ...

Huntington’s disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a progressive, hereditary brain disease that affects movement, cognition and emotions.